Literature DB >> 20187862

Animal models of headache: from bedside to bench and back to bedside.

Anna P Andreou1, Oliver Summ, Annabelle R Charbit, Marcela Romero-Reyes, Peter J Goadsby.   

Abstract

In recent years bench-based studies have greatly enhanced our understanding of headache pathophysiology, while facilitating the development of new headache medicines. At present, established animal models of headache utilize activation of pain-producing cranial structures, which for a complex syndrome, such as migraine, leaves many dimensions of the syndrome unstudied. The focus on modeling the central nociceptive mechanisms and the complexity of sensory phenomena that accompany migraine may offer new approaches for the development of new therapeutics. Given the complexity of the primary headaches, multiple approaches and techniques need to be employed. As an example, recently a model for trigeminal autonomic cephalalgias has been tested successfully, while by contrast, a satisfactory model of tension-type headache has been elusive. Moreover, although useful in many regards, migraine models are yet to provide a more complete picture of the disorder.

Entities:  

Mesh:

Year:  2010        PMID: 20187862     DOI: 10.1586/ern.10.16

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  26 in total

1.  The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.

Authors:  Alycia F Tipton; Igal Tarash; Brenna McGuire; Andrew Charles; Amynah A Pradhan
Journal:  Cephalalgia       Date:  2016-07-19       Impact factor: 6.292

Review 2.  Update on animal models of migraine.

Authors:  Marcela Romero-Reyes; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 3.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

Review 4.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 5.  Fibromyalgia and sleep in animal models: a current overview and future directions.

Authors:  Cristina Frange; Camila Hirotsu; Helena Hachul; Paula Araujo; Sergio Tufik; Monica L Andersen
Journal:  Curr Pain Headache Rep       Date:  2014

6.  Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia.

Authors:  Nathan T Fried; Christina R Maxwell; Melanie B Elliott; Michael L Oshinsky
Journal:  Cephalalgia       Date:  2017-04-29       Impact factor: 6.292

Review 7.  Mechanism of action of indomethacin in indomethacin-responsive headaches.

Authors:  Oliver Summ; Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2013-04

Review 8.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

9.  Spontaneous trigeminal allodynia in rats: a model of primary headache.

Authors:  Michael L Oshinsky; Menka M Sanghvi; Christina R Maxwell; Dorian Gonzalez; Rebecca J Spangenberg; Marnie Cooper; Stephen D Silberstein
Journal:  Headache       Date:  2012-09-10       Impact factor: 5.887

10.  α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia.

Authors:  Hung-Ruei Tzeng; Ming Tatt Lee; Pi-Chuan Fan; Daniel E Knutson; Tzu-Hsuan Lai; Werner Sieghart; James Cook; Lih-Chu Chiou
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.